Rashtriya Newsflash

Posts From admin

Sisi Hollywood: A Bridge Between East and West, Marked by One of Charlie Kirk’s Last Interviews

The shocking death of Charlie Kirk at just 31 has stirred debate and reflection across the United States. Known for his sharp views and strong influence, his sudden passing left

Read Full Article

Cushing’s Syndrome Pipeline 2025: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsight | Crinetics Pharma, AstraZeneca, Novartis, Sparrow Pharma, Corcept Therapeutics

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Cushing’s Syndrome pipeline constitutes 4+ key companies continuously working towards developing 4+ Cushing’s Syndrome treatment therapies, analysis of Clinical Trials,

Read Full Article

Sarcopenia Market Positioned for Accelerated Development Through 2034, DelveInsight Finds | TNF Pharma, Lipocine, Biophytis, ImmunoForge, Rejuvenate Biomed, Keros Therapeutics, BPGbio, Oncocross

The Key Sarcopenia Companies in the market include – TNF Pharmaceuticals, Lipocine, Biophytis, ImmunoForge, Rejuvenate Biomed, Keros Therapeutics, BPGbio, Oncocross, Mirscience Therapeutics, Turn Biotechnologies, NMD PHARMA, ImmunoForge, Dong Wha PHARM,

Read Full Article

Beta Thalassemia Pipeline 2025: Latest FDA Approvals, Clinical Trials, and Emerging Therapies Assessment by DelveInsight | Ionis Pharmaceuticals, Inc., Agios Pharma, Silence Therapeutics, Phoenicia

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Beta Thalassemia pipeline constitutes 22+ key companies continuously working towards developing 22+ Beta Thalassemia treatment therapies, analysis of Clinical Trials,

Read Full Article

Fuchs Endothelial Corneal Dystrophy Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight Observes | ProQR Therapeutics, Kowa Pharmaceuticals, Trefoil Therapeutics, Alcon Inc., Emmecell

The Key Fuchs Endothelial Corneal Dystrophy Companies in the market include – ProQR Therapeutics, Kowa Pharmaceuticals, Trefoil Therapeutics, Alcon Inc.,

Read Full Article

Surgical Site Infections Pipeline 2025: Comprehensive Clinical Trials and Therapies Analysis with Key MOA and ROA Insights by DelveInsight | Destiny Pharma plc, MinaPharm Pharma, Duke Clinical Researc

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Surgical Site Infections pipeline constitutes 5+ key companies continuously working

Read Full Article

Severe Asthma Market Insights Highlight Expanding Outlook Till 2034, DelveInsight Evaluates | Sanofi, GlaxoSmithKline, EMS, Oneness Biotech, Incyte Corp, CSPC ZhongQi Pharma, AstraZeneca

The Key Severe Asthma Companies in the market include – Teva Pharmaceutical, AstraZeneca, Upstream Bio Inc., Oneness Biotech Co., Chia

Read Full Article

Synovial Sarcoma Pipeline 2025: FDA Approvals, Therapies, Clinical Trials, and Latest Developments Unveiled by DelveInsight | Advenchen Laboratories, Ipsen, Daiichi Sankyo, EpiZyme Inc, Merck & Co

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Synovial Sarcoma pipeline constitutes 15+ key companies continuously working towards

Read Full Article

Royal Dragons Cup Website Launches Ahead of Festival on 23rd May 2026

The organisers of the Royal Dragons Cup are proud to announce the official launch of their new website, royaldragonscup.co.uk, going

Read Full Article

Global Coronary Angiography Devices Market to Reach USD 21.59 Billion by 2032, Driven by Rising Cardiovascular Disease Burden and Technological Advancements, Says DelveInsight

Global Coronary Angiography Devices Market The Global Coronary Angiography Devices Market is poised for robust expansion, projected to grow from

Read Full Article